Risk Factor Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Risk Factor Profile. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Risk Factor Profile Today - Breaking & Trending Today

GenFleet Receives FDA Approval for Phase II Study of RIPK1 Inhibitor (GFH312)

Published: August 18, 2022

/PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food...

Source: prnewswire.com

Related Topics:

Yu WangNova Science Pub IncUniversity Of Colorado Anschutz Medical CampusDrug AdministrationChina HypertensionGenfleet TherapeuticsColorado Anschutz MedicalChief Medical OfficerJiong LanChief Executive OfficerArterial DiseaseRisk Factor ProfileClinical FeaturesCurr Atheroscler RepChina Hypertension SurveyIntj Cardio